Steinbjørn Hansen

Medicin og biovidenskab

1. Glioblastoma 100%
2. Prostatic Neoplasms 79%
3. Glioma 78%
4. Radiotherapy 52%
5. Survival 51%
6. Castration 35%
7. Neoplasms 32%
8. Temozolomide 31%
9. Docetaxel 31%
10. Breast Neoplasms 27%
11. Denmark 26%
12. cabazitaxel 25%
13. Irinotecan 24%
14. Bevacizumab 23%
15. Isocitrate Dehydrogenase 23%
16. Registries 21%
17. Junctional Adhesion Molecule A 18%
18. Acetylene 17%
19. Progression-Free Survival 17%
20. Rehabilitation 16%
21. Prostatectomy 16%
22. Neoplastic Stem Cells 16%
23. Microvessels 15%
24. Cardiac Output 15%
25. Therapeutics 15%
26. Ipilimumab 14%
27. Nestin 14%
28. Androgens 14%
29. Brain Neoplasms 14%
30. Population 14%
31. Mitoxantrone 13%
32. Astrocytoma 13%
33. Plasminogen Activator Inhibitor 1 11%
34. Prednisone 11%
35. Quality of Life 11%
36. DNA-3-methyladenine glycosidase II 9%
37. Noble Gases 9%
38. Observer Variation 8%
39. Biomarkers 8%
40. Confidence Intervals 8%
41. Microglia 8%
42. Protein Methyltransferases 8%
43. Prostate-Specific Antigen 8%
44. Chemoradiotherapy 8%
45. Apoferritins 7%
46. Methyltransferases 7%
47. Databases 7%
48. DNA Glycosylases 7%
49. Pelvic Floor 7%
50. Multivariate Analysis 7%